A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


April 17, 2012

FDA Considers Overdose Antidote for Over-the-Counter Use

The Food and Drug Administration (FDA) is considering whether to allow non-prescription use of naloxone (Narcan), which can prevent opioid overdose from heroin or Vicodin, Time.com reports. Opioid-based substances can slowly stop a person’s breathing. They cause about 15,000 lethal overdoses in the United States every year. However, if naloxone is administered during this slow cessation of breathing, it can block the receptors for opioid drugs, thereby reversing their effects and restoring normal breathing.

Many argue that naloxone administered by emergency medical technicians (EMTs) and hospital staff has saved thousands of lives, and that if this non-addictive, non-narcotic drug were more widely available for use without a prescription, more people would have the drug on hand and it could save lives.

The FDA’s procedure for changing the status of the drug to non-prescription would require a pharmaceutical company to submit an application and to supply data showing evidence regarding the drug’s safety. Alternatively, a citizens’ petition could push the FDA to make the drug available without a prescription, but this procedure may take years.

To read the Time.com article, click here.

Search: Food and Drug Administration, FDA, prescription, Narcan, naloxone, opioid, Vicodin, heroin, overdose, overdoses, emergency medical technicians, EMTs, EMT,

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.